INTRODUCTION
============

The oral candidiasis known as denture stomatitis is related to the use of removable dentures and is considered the most common oral lesion observed (65%)^[@r27]^ in patients wearing removable dentures. Although the etiology of denture stomatitis is multifactorial, infection by *Candida spp.,* especially *C. albicans*, is considered the main etiologic factor. Local factors associated with the denture are also related to this pathology, such as: presence of biofilm^[@r04],[@r18]^, local trauma caused by dentures12, xerostomia^[@r21]^, continuous use of the dentures and alteration in salivary pH^[@r12]^.

Different treatments for denture stomatitis are available and may include topical antifungal and systemic therapy, care with oral hygiene, denture cleaning and disinfection procedures^[@r18]^, replacement of old dentures, elimination of anatomic irregularities, re-establishment of atraumatic occlusion, and nutritional restitution^[@r03]^. Furthermore, in order to protect and preserve the integrity of the mucosal epithelium, patients should sleep without the dentures^[@r06]^. The choice of a treatment or association of more than one treatment is an aspect to be individually considered. Re-infection of the treated oral mucosa may occur in up to two weeks post-treatment, and is attributed to the survival of *Candida spp*. due to insufficient concentration of the antifungal agent on the denture surfaces^[@r16]^. Therefore, it is crucial to adopt methods that reduce or preferably eliminate the microorganisms from denture surfaces.

In addition, resilient materials have been routinely used with the purpose of recovering tissues that are in contact with the denture base^[@r24]^. These materials partially absorb chewing load on the denture during function, thus reducing the energy transmitted to the associated paraprosthetic tissues^[@r17]^. However, these materials are easily degradable and susceptible to microbial colonization^[@r14]^, which may cause different degrees of denture stomatitis.

To prolong the clinical longevity of resilient materials and reduce plaque accumulation, incorporation of antimicrobial agents into these materials has been proposed^[@r20]^. This combination may be a logical therapy in the treatment of denture stomatitis because of several factors: 1. reducing the trauma caused by the internal surface of removable dentures; 2. eliminating contact of the contaminated surface with the oral tissues and consequently, interrupting the cycle of re-infection, and 3. action of antimicrobial agents incorporated into the material on the infected tissues^[@r20]^. In this context, denture stomatitis may be treated before fabricating new dentures, in a relatively short period. The reason is attributed to their gradual degradation and hardening, so it should not take longer than two weeks, which is a period similar to the one required for the treatment with conventional topical antifungal drugs^[@r20],[@r22]^.

The incorporation of antimicrobial agents into resilient materials has shown to be effective and feasible both in *in vitro* and *in vivo* studies^[@r06],[@r20],[@r22]^. Despite these therapeutic advantages, the incorporation of drugs into polymeric materials, including tissue conditioners and resilient liners, may affect their properties. For the resilient liner to adequately perform its function of recovering the tissues injured by trauma, it should remain bonded to the acrylic base of the removable denture5. Peeling of the resilient material from the denture base has been reported as the cause of clinical failure and the bond between the resilient materials and the denture base acrylic resins has been the object of previous investigations^[@r13],[@r17]^. Thus, the aim of this study was to evaluate the effect of the addition of antimicrobial agents (nystatin, miconazole, ketoconazole, and chlorhexidine diacetate) to a resilient liner on its peel bond strength to a denture base acrylic resin. The hypothesis investigated in this study was that the addition of antimicrobial agents to a resilient liner would result in changes in the peel bond strength to a denture base acrylic resin.

MATERIAL AND METHODS
====================

The acrylic materials, manufacturers, batch numbers, compositions, powder/liquid ratios, and polymerization conditions selected for this study are listed in [Figure 1](#f01){ref-type="table"}. The selected antimicrobial agents were nystatin, miconazole, ketoconazole (Alonatu Farmácia de Manipulação e Cosméticos/Farmácia Dermatus, Maceió, AL, Brazil - Req. 119704-1), and 98% chlorhexidine diacetate (Acros Organics, Morris Plains, NJ, USA).

###### 

Materials selected for this study

  **Materials**   **Type**                    **Manufacturer**                                   **Batch number**   **Composition**                                                       **Powder/ liquid ratio**   **Polymerization conditions**
  --------------- --------------------------- -------------------------------------------------- ------------------ --------------------------------------------------------------------- -------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Soft Confort    Resilient liner             Dencril Prod. Odontol., São Paulo, SP, Brazil      Powder (010068)    Poly(ethyl methacrylate), phtalate ester, ethyl alcohol               1.27 g/1 mL                5 min at room temperature
  QC 20           Heat-curing acrylic resin   Dentsply Ind. Com. Ltda., Petrópolis, RJ, Brazil   Liquid (503793)    Poly(methyl methacrylate), methyl methacrylate,n-butyl methacrylate   2.3 g/1 mL                 1\. Heat water to boiling point; 2. Turn off the water bath; 3. Put the flask in and leave it for 20 min; 4. Turn on the water bath; 5. When the boiling point is reached, wait another 20 min.

Specimen preparation
--------------------

Specimens (n=9)^[@r17]^ measuring 75x10x3 mm^[@r13],[@r17]^ of heat-curing acrylic resin QC 20 (Dentsply Ind. e Com. Ltda., Petrópolis, RJ, Brazil) were made. For this purpose, stainless steel matrixes measuring 75x10x3 mm were molded using laboratory silicone (Zetalabor, Rovigo, Veneto, Italy) between two glass plates. The mold/matrix set was invested in conventional metal dental flasks in Type III dental stone (Herodent, Vigodent, Rio de Janeiro, RJ, Brazil). The dental flasks were closed and remained under pressure (500 kgf) in a hydraulic press during stone setting time. After this period, the dental flasks were opened and the stainless steel matrixes were removed.

QC 20 was proportioned, mixed according to the manufacturer\'s instructions ([Figure 1](#f01){ref-type="table"}), and was inserted into the silicone matrix mold. The dental flask was closed and kept under pressure at room temperature (23±2ºC) for 30 min. After this period, the test specimens were submitted to the polymerization cycle \"B\" recommended by resin manufacturer ([Figure 1](#f01){ref-type="table"}). When the polymerization cycle ended, the dental flasks were bench cooled for 30 min and then under running water for 15 min. The specimens were removed from the molds and stored in distilled water at 37ºC for 48 h^[@r10]^.

After this period, specimens were submitted to surface preparation to receive the modified resilient liner. One of the specimen surfaces was abraded automatically in a polishing machine using \#600 silica carbide abrasive paper (Norton Abrasivos, São Paulo, SP, Brazil). The abraded surface was cleaned with detergent for 20 s, washed under running water, and dried. The specimen was then placed in a hollow stainless steel mold with internal measurements of 75x10x6 mm. The specimen area (650 mm^2^) to not be bonded to the resilient material was covered with a polyester strip.

The antimicrobial powders in each experimental group ([Figure 2](#f02){ref-type="table"}) were manually mixed with resilient lining powder with a spatula, until a homogenous mixture was obtained^[@r24],[@r25]^. The resilient lining liquid was added to this mixture and the material was mixed in accordance to the manufacturer\'s instructions ([Figure 1](#f01){ref-type="table"}). The modified material was inserted into the hollow mold containing the test specimen of the heat-curing acrylic resin prepared for the relining procedure. This set was covered with glass slide and kept under finger pressure during the resilient liner polymerization time recommended by the manufacturer ([Figure 1](#f01){ref-type="table"}). The excesses of the modified resilient liner were eliminated and the specimen was removed from the mold. The relined specimens were then stored in distilled water at 37ºC for 24 h prior to the peel test.

###### 

Drug dosages incorporated into the resilient liner powder in all experimental groups

  **Group**   **Antimicrobial agent**   **Amount of drug incorporated**
  ----------- ------------------------- ---------------------------------
  G1          None (control)            None
  G2          Nystatin                  500,000 U
  G3          Nystatin                  1,000,000 U
  G4          Miconazole                125 mg
  G5          Miconazole                250 mg
  G6          Ketoconazole              100 mg
  G7          Ketoconazole              200 mg
  G8          Chlorhexidine diacetate   5%
  G9          Chlorhexidine diacetate   10%

Peel test
---------

A universal testing machine (Versat 2000, Panambra Ind. Tech. SA, São Paulo, SP, Brazil) was used to perform the peeling bond strength test of the relined test specimens at an angle of 180º. A portion of modified resilient material not bonded to the resin base (65 mm) was folded upwards and fixed onto the top hook of the equipment at 20 mm from the adhesive bond area of the test specimen. The other un-relined portion of the heat-curing acrylic resin was fixed onto the bottom hook of the equipment^[@r13],[@r17]^ at the same distance from the adhesive bond area. Each test specimen was submitted to tension to promote peeling of the modified resilient liner from the heat-curing acrylic resin base at a speed of 10 mm/min until failure occurred.

Bond failures were visually observed and classified into three categories: adhesive, when peeling occurred between the modified resilient liner and the denture base acrylic resin; cohesive, when there was tearing (rupture of the resilient liner within the area bonded to the denture base) or snapping (resilient material had stretched and then ruptured away from the bonded area) within the modified resilient liner; and mixed, when regions with two types of failure were observed on the surface of the denture base material^[@r13],[@r17]^.

The results of rupture force were initially obtained in N and transformed into peeling bond strength in MPa and then submitted to one-way ANOVA at a significant level of 5%.

RESULTS
=======

The results of peel bond strength are shown in [Table 1](#t01){ref-type="table"}. There was no significant difference (p=0.148) among the experimental groups. Therefore, the incorporation of antimicrobial agents in the concentrations assessed did not affect the peeling bond strength between the resilient liner and the denture base resin after 24 h of immersion in distilled water.

###### 

Peel strength (MPa) at 24 h

  **Experimental groups**   **Mean (SD)[\*](#t01-fn01){ref-type="table-fn"}**   **Mode of failure**
  ------------------------- --------------------------------------------------- ---------------------------------------
  G1                        0.054 (0.017)                                       80% cohesive; 20% mixed
  G2                        0.049 (0.017)                                       All cohesive
  G3                        0.043 (0.012)                                       80% cohesive; 20% mixed
  G4                        0.046 (0.013)                                       80% cohesive; 20% mixed
  G5                        0.042 (0.014)                                       All cohesive
  G6                        0.046 (0.012)                                       40% cohesive; 40% mixed; 20% adhesive
  G7                        0.050 (0.010)                                       80% cohesive; 20% mixed
  G8                        0.060 (0.012)                                       All cohesive
  G9                        0.049 (0.012)                                       80% cohesive; 20% mixed

There was no statistical difference (p\>0.05) among the experimental groups

The failure modes obtained after performing the tests are shown in [Table 1](#t01){ref-type="table"}. The majority of bond failures were cohesive (tearing and/or snapping) within the resilient liner. For the experimental groups G2 (nystatin at 500,000 U), G5 (miconazole at 250 mg), and G8 (5% chlorhexidine diacetate), a mixture of tearing and snapping was observed. Peeling away from the denture base was only observed for groups G6 (ketoconazole at 100 mg) and G9 (10% chlorhexidine diacetate). For the other groups, cohesive and mixed bond failures were observed.

DISCUSSION
==========

The hypothesis investigated in this study that \"the addition of antimicrobial agents to the resilient liner would result in alterations in the peeling bond strength to denture base resin\" was rejected because there was no difference between the experimental groups assessed in comparison with the control group without the addition of drugs.

During clinical use, the resilient materials are highly subjected to degradation and susceptible to the colonization by microorganisms. If these materials are not regularly replaced, they may act as microorganism reservoirs, causing systemic complications^[@r23]^. An example of this is the presence in the oral cavity of *Staphylococcus aureus*, a microorganism responsible for respiratory infections^[@r15]^. The combination between resilient materials and antimicrobial agents seems to be a logical therapeutic modality for denture stomatitis. This method results in a reduction of the trauma caused by the old denture and tissue reconditioning associated with antimicrobial therapy; important etiologic factors in triggering infection by *Candida*spp. are simultaneously eliminated. In addition, this method favors a relined denture that can more easily be kept clean by the patient^[@r20]^.

Several drugs have shown reduced water solubility, so maximum dose is required to have the effectiveness required for a certain medication^[@r08]^. Among the antimicrobial agents assessed, chlorhexidine shows higher solubility in water, followed by nystatin, miconazole, and ketoconazole^[@r08]^. Although these medications are soluble in water, they are insoluble in monomers and plasticizers^[@r01]^.Thus, they could not interfere with the polymerization or plasticization^[@r01]^ process of these materials. However, their physical presence within the polymer matrix could interrupt the structure of the polymerized materials^[@r21]^. Resilient materials containing nystatin showed increased water sorption, and for these materials, this resulted in breaking their morphological structure^[@r07]^. According to Addy and Handley^[@r02]^ (1981), change in material properties may be consistent with the incorporation pattern of the medication into the polymer matrix. A previous study^[@r24]^ assessed the incorporation pattern of antimicrobial agents into a tissue conditioner with the same concentrations to those investigated in this study, by scanning electronic microscopy (SEM) and energy dispersive spectroscopy x-ray (eDS). The test specimens containing nystatin and miconazole exhibited particles with irregular shapes and sizes distributed uniformly within the tissue conditioner matrix while specimens with chlorhexidine exhibited more irregular particles distributed randomly within the material. However, these alterations would not prevent the incorporation of drugs for release in the oral cavity if they were added to materials to reline already existent dentures^[@r02]^, without necessarily reducing their strength.

Although some soft materials are submitted only to compression and shear, tensile strength is used to measure the quality of the material. The ability of the material to resist tearing is of practical importance. In clinical use, including the cleaning and disinfection procedures, the soft materials are submitted to conditions that start the tearing process. Adequate bonding between denture base resin and soft material is therefore essential. Clinical failure of these materials is frequently attributed to the rupture of this bond, and the measurements of this bond are clinically relevant. Reduced bond between the soft liner and the denture base resin effectively negates any other property considered adequate for this material^[@r26]^. In the peel bond strength test, the stress is confined to a line restricted to the end of the bond, and is considered the most clinically representative of the failure modes^[@r26]^. This is the only method in which the failure proceeds at controlled speed and it is a direct measure of peeling, while it also represents the elastic deformation of the material^[@r09]^. The peeling test simulates the lining procedure more precisely, with a uniform and constant distribution of force throughout the bond area^[@r26]^.

The results of this study demonstrated that the addition of antimicrobial agents in all the assessed concentrations did not affect the peeling bond strength of the resilient liner to denture base resin. However, the bond strength values were considered low, since they were approximately 10 times lower than the acceptable value for the clinical use of resilient liners (0.44 MPa)^[@r11]^.

While the methodology in this study was performed, some modifications were made, such as the reduction in bond area and surface roughness of the denture base, to ensure that the methodology evaluated the bonding between materials rather than the cohesive strength of the liner material. If the bond failures observed in this study were predominantly cohesive within the liner material, the peeling bond strength would not be measured^[@r09]^. The failure mode of the cohesive type provides information related to the material itself and not to the bond between materials^[@r19]^. emmer, et al.^[@r08]^ (1995) suggested the term \"strength failure\" instead of \"bond failure\" when cohesive failures occur. Predominant cohesive failures, such as those that occurred in this study, indicate poor resistance to tearing of the resilient material. However, mixed and adhesive failures were observed in some samples, indicating that the cohesive strength values of the resilient liner and bond strength values to base resin were similar.

A previous study^[@r25]^ observed that a tissue conditioner (Duraconditioner, Reliance Manufacturing nystatin showed cohesive strength values similar to those of the control group. These values were close, if not similar, to the ones obtained in this study. Therefore, the cohesive strength of the resilient material tested in this study is equivalent to its bond strength to the denture base material. Thus, the material will snap or tear at the bond interface at forces lower than those necessary to cause bond failures.

One of the limitations of this study was that only one brand of the resilient liner was assessed. Moreover, the peeling bond strength could have been assessed after other storage periods. This assessment is also important to observe a possible reduction in bond strength of the modified liner to the denture base material, since it has been reported that plasticizers and alcohols are released from resilient materials after periods of storage in water and this release is responsible for the decrease in the bond strength values between the materials^[@r13]^. However, these analyses are object of future investigations.

CONCLUSIONS
===========

Within the limitations of this *in vitro*study, it can be concluded that it is possible to incorporate any of the antimicrobial agents assessed in the selected concentrations into a resilient liner without changing the bond strength of this material to denture base resin. A clinical study is still needed to determine the therapeutic validity of this alternative treatment modality.
